imatinib mesylate has been researched along with ATLL in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Z; Li, Z; Liang, A; Tian, X; Yang, M; Yu, W; Zhang, W; Zhou, J | 1 |
| Avramis, IA; Avramis, VI; Laug, WE; Sausville, EA | 1 |
| Boeckx, N; Bosly, A; Cools, J; Drexler, HG; Dutta, B; Ferrando, A; Gilliland, DG; Graux, C; Hagemeijer, A; Heimann, P; Levine, R; Look, AT; MacLeod, RA; Marynen, P; Melotte, C; Mentens, N; Michaux, L; Quentmeier, H; Somers, R; Stul, M; Uyttebroeck, A; Vandenberghe, P; Vermeesch, JR; Wlodarska, I | 1 |
| Fox, C; Russell, NH; Stergianou, K | 1 |
| Burmeister, T; Gökbuget, N; Hoelzer, D; Reinhardt, R; Rieder, H; Schwartz, S | 1 |
| Angelucci, E; Barbui, T; Bassan, R; Fabris, P; Grassi, A; Guerini, V; Intermesoli, T; Lambertenghi-Deliliers, G; Micò, C; Oldani, E; Peruta, B; Rambaldi, A; Rossi, G; Salvi, A; Spinelli, O; Tosi, M; Zanotti, MC | 1 |
| Bekaert, S; Cools, J; De Keersmaecker, K; Folens, C; Lahortiga, I; Marynen, P; Mentens, N; Odero, MD; Van Neste, L; Vandenberghe, P | 1 |
| Cools, J; Cortes, J; Garcia-Manero, G; Gilliland, DG; Kantarjian, H; Lee, F; Lennon, PA; Manshouri, T; Quintás-Cardama, A; Tong, W; Vega, F | 1 |
8 other study(ies) available for imatinib mesylate and ATLL
| Article | Year |
|---|---|
Targeting RAD51 enhances chemosensitivity of adult T‑cell leukemia‑lymphoma cells by reducing DNA double‑strand break repair.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; DNA Breaks, Double-Stranded; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Knockdown Techniques; HEK293 Cells; Humans; Imatinib Mesylate; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Rad51 Recombinase; Recombinational DNA Repair; RNA, Small Interfering | 2019 |
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Topics: Adamantane; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Hydroquinones; Imatinib Mesylate; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Vascular Endothelial Growth Factor A; Vidarabine Phosphate | 2003 |
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.
Topics: Amino Acid Sequence; Artificial Gene Fusion; Base Sequence; Benzamides; Cell Line, Tumor; Chromosomes, Human, Pair 9; DNA, Neoplasm; Enzyme Inhibitors; Gene Amplification; Genes, abl; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia-Lymphoma, Adult T-Cell; Molecular Sequence Data; Nuclear Pore Complex Proteins; Piperazines; Plasmids; Protein-Tyrosine Kinases; Pyrimidines | 2004 |
Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Artificial Gene Fusion; Benzamides; Gene Amplification; Genes, abl; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia-Lymphoma, Adult T-Cell; Male; Nuclear Pore Complex Proteins; Piperazines; Plasmids; Pyrimidines; Recurrence | 2005 |
NUP214-ABL1 in adult T-ALL: the GMALL study group experience.
Topics: Adolescent; Adult; Benzamides; Female; Humans; Imatinib Mesylate; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Piperazines; Polymerase Chain Reaction; Prognosis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pyrimidines; RNA, Messenger; Survival Rate | 2006 |
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Benzamides; Biomarkers, Tumor; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Female; Fusion Proteins, bcr-abl; Gene Deletion; Gene Rearrangement, B-Lymphocyte; Gene Rearrangement, T-Lymphocyte; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Kinetics; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Multicenter Studies as Topic; Myeloid-Lymphoid Leukemia Protein; Neoplasm, Residual; Oncogene Proteins, Fusion; Piperazines; Polymerase Chain Reaction; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Pyrimidines; Remission Induction; Risk; Survival Analysis; Survival Rate; T-Cell Acute Lymphocytic Leukemia Protein 1; Translocation, Genetic; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2007 |
In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
Topics: Amyloid Precursor Protein Secretases; Antineoplastic Agents; Apoptosis; Benzamides; Benzodiazepinones; Carbamates; Cell Cycle; Cell Division; Cell Line, Tumor; Daunorubicin; Dexamethasone; Dipeptides; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia-Lymphoma, Adult T-Cell; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Notch1; Sequence Analysis, DNA; Vincristine | 2008 |
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.
Topics: Adaptor Proteins, Signal Transducing; Adult; Animals; Apoptosis; Benzamides; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; Dasatinib; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Experimental; Male; Mice; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; STAT5 Transcription Factor; Thiazoles; Tumor Cells, Cultured | 2008 |